Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

Home > Science Hub > Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
Back to the list

April 12, 2022

Dirix L et al. Breast Cancer Research and Treatments, 2022

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

Download Publication

You might also be interested by

Webcasts & Webinars

Let's Talk: A Conversation with Dr. Thomas Powles

December 19, 2024

More info

News

Let's Talk: A Conversation with Dr. Thomas Powles

November 28, 2024

More info

Posters

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

November 19, 2024

More info

Posters

Accelerating analysis of cytometry data sets leveraging a visualization tool built within CellEngine, a cloud-based cytometry analysis software

November 7, 2024

More info